Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Date for your diaries: Wednesday 2nd December 2020. Precise timings to follow as we are currently working on the logistics of holding MitOX as a web-based event, due to the Covid-19 pandemic.

Copyright: Shutterstock

MITOX 2020

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2020 on Wednesday 2nd December 2020. It's our annual meeting packed with short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.

about mitox

Date:  Wednesday 2nd December 2020.  Precise timings to follow as we are currently working on the logistics of holding MitOX as a web-based event, due to the Covid-19 pandemic. 

This one day meeting is ideal for researchers with an interest in mitochondria from academia and pharma. It will include a range of short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.  

 

SPEAKERS 

Mark Crabtree

Citrate and itaconate in inflammatory activation in cardiovascular medicine.

University of Oxford

Jessica Whitburn

Metabolic profiling of prostate cancer cells within skeletal microenvironments identifies G6PD as a key mediator of bone-metastatic prostate cancer growth and survival.

University of Oxford

Nicholas T Ktistakis

The dynamics of mitochondrial autophagy (Pollard Lecture)

Babraham Institute, University of Cambridge

Jo Poulton

Mitophagy in mitochondrial diseases.

University of Oxford

Jo Howson

MtDNA and diabetes.

University of Oxford

Carolyn Carr

Can we model the diabetic human heart in a dish using iPSC-derived cardiomyocytes?

University of Oxford

Karl Morten

Plasma Metabolomics in ME/CFS: a tale of two cohorts.

University of Oxford

Bhupesh Prusty

Mitochondrial architecture decides the niche for pathogenic survival.

University of Wuerzburg, Germany

  James Hulit 

Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells.

 Novintum, London 

Michael Skwarski 

Repurposing atovaquone as a novel tumour hypoxia modifier: results from the ATOM clinical trial.

University of Oxford

James Mccullagh                   

IDH mutations in cancer.    

University of Oxford